Patient Guide: A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 37 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05232825
Status: COMPLETED
Condition: Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis
Phase: PHASE3

Find a Study Location Near You

This study is available at 37 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Maitland, Florida
  • Tampa, Florida
  • Baltimore, Maryland
  • • And 34 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily